Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Gottschalk

Showing results (31-40 of 227) with videos related to

Pageof 23
Sort By:
Cell Reports. Medicine|February 18, 2026
Cell therapy for brain tumors: The first 60 yearsSanya Mehta, Giedre Krenciute, Stephen Gottschalk
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid TumorsChristopher DeRenzo, Giedre Krenciute, Stephen Gottschalk
Haematologica|June 4, 2024
Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application?Swati Naik, M Paulina Velasquez, Stephen Gottschalk
Frontiers in Oncology|March 19, 2020
A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell TherapyRebecca Epperly, Stephen Gottschalk, M Paulina Velasquez
Cytotherapy|June 13, 2021
Transient blockade of TBK1/IKKε allows efficient transduction of primary human natural killer cells with vesicular stomatitis virus G-pseudotyped lentiviral vectorsPeter Chockley, Sagar L Patil, Stephen Gottschalk
Immunity|August 20, 2020
Preventing Ubiquitination Improves CAR T Cell Therapy via 'CAR Merry-Go-Around'Nicole M Chapman, Stephen Gottschalk, Hongbo Chi
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2015
Response to "in vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement"Kota Iwahori, Xiao-Tong Song, Stephen Gottschalk
Children (Basel, Switzerland)|February 22, 2020
Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and BeyondRebecca Epperly, Stephen Gottschalk, Mireya Paulina Velasquez
Hematology. American Society of Hematology. Education Program|December 9, 2023
Preventing relapse after CD19 CAR T-cell therapy for pediatric ALL: the role of transplant and enhanced CAR T cellsAimee C Talleur, Swati Naik, Stephen Gottschalk
Immunotherapy|December 1, 2012
Cancer-associated fibroblasts as targets for immunotherapySunitha Kakarla, Xiao-Tong Song, Stephen Gottschalk
Pageof 23

Showing results (31-40 of 227) with videos related to

Sort By:
Pageof 23
Cell Reports. Medicine|February 18, 2026
Cell therapy for brain tumors: The first 60 yearsSanya Mehta, Giedre Krenciute, Stephen Gottschalk
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid TumorsChristopher DeRenzo, Giedre Krenciute, Stephen Gottschalk
Haematologica|June 4, 2024
Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application?Swati Naik, M Paulina Velasquez, Stephen Gottschalk
Frontiers in Oncology|March 19, 2020
A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell TherapyRebecca Epperly, Stephen Gottschalk, M Paulina Velasquez
Cytotherapy|June 13, 2021
Transient blockade of TBK1/IKKε allows efficient transduction of primary human natural killer cells with vesicular stomatitis virus G-pseudotyped lentiviral vectorsPeter Chockley, Sagar L Patil, Stephen Gottschalk
Immunity|August 20, 2020
Preventing Ubiquitination Improves CAR T Cell Therapy via 'CAR Merry-Go-Around'Nicole M Chapman, Stephen Gottschalk, Hongbo Chi
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2015
Response to "in vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement"Kota Iwahori, Xiao-Tong Song, Stephen Gottschalk
Children (Basel, Switzerland)|February 22, 2020
Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and BeyondRebecca Epperly, Stephen Gottschalk, Mireya Paulina Velasquez
Hematology. American Society of Hematology. Education Program|December 9, 2023
Preventing relapse after CD19 CAR T-cell therapy for pediatric ALL: the role of transplant and enhanced CAR T cellsAimee C Talleur, Swati Naik, Stephen Gottschalk
Immunotherapy|December 1, 2012
Cancer-associated fibroblasts as targets for immunotherapySunitha Kakarla, Xiao-Tong Song, Stephen Gottschalk
Pageof 23